Chemotherapy-related cardiac dysfunction, also known as cardiotoxicity, is a group of drug-
related adverse events negatively affecting myocardial structure and functions in patients …

Thrombotic events are a major cause of morbidity and mortality in cancer. While the
association of venous thromboembolic events with cancer is well documented, in recent …

Immunomodulatory drugs (IMiDs) have improved survival of patients with multiple myeloma
(MM) and comprise the therapeutic backbone at all phases of therapy. Although well …

Clinical studies investigating the effect of different treatments on MM patients have revealed
thromboembolic complications as common occurrences, particularly in combined treatment …

Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes
(POEMS) syndrome is an uncommon multisystemic disease associated with plasma cell …

Multiple myeloma (MM) has been associated with an increase in the risk of venous
thromboembolism (VTE) and death. Several risk factors of VTE include patients, diseases …